(E)-3-(p-isopropylphenyl)prop-2-en-1-ol | 274907-08-3

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: (E)-3-(p-isopropylphenyl)prop-2-en-1-ol
• 英文别名: (E)-3-(4-isopropylphenyl)prop-2-en-1-ol；(E)-3-(4-isopropylphenyl)-2-propen-1-ol；(E)-3-(4-Isopropylphenyl)-2-propen-l-ol；4-isopropyl-cinnamyl alcohol；3-Hydroxy-1-(4-isopropyl-phenyl)-propen-(1)；3-(4-Isopropyl-phenyl)-allylalkohol；3-p-Cumenyl-allylalkohol；4-Isopropyl-zimtalkohol；(2E)-3-[4-(Propan-2-yl)phenyl]prop-2-en-1-ol；(E)-3-(4-propan-2-ylphenyl)prop-2-en-1-ol
• CAS: 274907-08-3
• 化学式: C₁₂H₁₆O
• 分子量: 176.258
• InChiKey: BEGXKHKITNIPEP-ONEGZZNKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2906299090

反应信息

• 作为反应物：
  描述：

  (E)-3-(p-isopropylphenyl)prop-2-en-1-ol 在 重铬酸吡啶 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 1.5h， 生成 4-异丙基肉桂醛
  参考文献：
  名称：

  手性酮催化的无环仲烯丙基甲硅烷基醚的动力学拆分。

  摘要：

  研究了由手性酮（R）-1和（R）-2和Oxone原位生成的手性二恶英酮对无环仲烯丙基甲硅烷基醚的动力学拆分。已经开发出一种有效的催化方法来动力学拆分那些在α位置具有CCl（3），叔丁基或CF（3）基团的底物。特别地，对于酮（R）-2催化的外消旋α-三氯甲基烯丙基甲硅烷基醚7和9-15的动力学拆分，观察到高选择性（S高达100）。回收的底物和所得的环氧化物均以高对映体过量获得。根据手性二恶英和外消旋底物之间的空间和静电相互作用，

  DOI：

  10.1021/jo010068c
• 作为产物：
  描述：

  methyl (E)-p-isopropylcinnamate 在 锂硼氢 作用下， 以 四氢呋喃 、 乙醚 为溶剂， 反应 16.0h， 以81%的产率得到(E)-3-(p-isopropylphenyl)prop-2-en-1-ol
  参考文献：
  名称：

  Synthesis, characterization and antiproliferative activity of β-aryl-δ-iodo-γ-lactones

  摘要：

  A convenient pathway for the synthesis of new of beta-aryl-delta-iodo-gamma-lactones is described. The synthetic route led to both cis and trans isomers which were separated by column chromatography or crystallization. The structures of synthesized compounds were confirmed by spectroscopic methods: IR, NMR and HR-MS. For lactones with naphthyl ring (6e and 7e) the crystal structures were also obtained. The lactones were screened for biological evaluation against cancer line HL-60 (human promyelocytic leukemia). The tests showed that the presence of substituent at the benzene ring does not significantly affect the antiproliferative activity of the compound. (C) 2013 Elsevier B.V. All rights reserved.

  DOI：

  10.1016/j.molstruc.2013.05.010

文献信息

• Palladium-Catalyzed Regioselective Aerobic Allylic C−H Oxygenation: Direct Synthesis of <i>α,β</i> -Unsaturated Aldehydes and Allylic Alcohols
  作者：Chunsheng Li、Huoji Chen、Jianxiao Li、Meng Li、Jianhua Liao、Wanqing Wu、Huanfeng Jiang

  DOI：10.1002/adsc.201701324

  日期：2018.4.17

  A protocol for the synthesis of α,β‐unsaturated aldehydes and allylic alcohols from simple allylic hydrocarbons with water via palladium‐catalyzed functionalization of allylic C−H bonds was described. Molecular oxygen is utilized as the sole oxidant in this oxygenation of terminal alkenes. This protocol features good functional group compatibility, broad substrate scope, and high atom‐ and step‐economy

  描述了通过钯催化的烯丙基CH键的官能化，由简单的烯丙基烃与水合成α，β-不饱和醛和烯丙基醇的方案。在末端烯烃的这种氧化中，分子氧被用作唯一的氧化剂。该协议具有良好的官能团兼容性，广泛的底物范围以及高原子经济性和阶梯经济性。而且，该方法在合成布洛芬中的应用可以突出该方法的合成效用，布洛芬是一种非常有效的止痛药。
• HETEROAROMATIC COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR AGONIST BIOLOGICAL ACTIVITY
  申请人：Beard Richard L.

  公开号：US20080064872A1

  公开（公告）日：2008-03-13

  A novel compound having agonist activity at the S 1 P 3 receptor which is represented by the formula I wherein X is selected from the group consisting of CR 3 , N and NO; Y is selected from the group consisting of CR 3 , N and NO; Z is selected from the group consisting of CR 3 , N and NO; and at least one of X, Y and Z is N or NO; V is O or NOR 4 R 1 is an aryl group; R 2 is an aryl group; R 3 is selected from the group consisting of H and alkyl; and 2 of said R 3 groups may together form a cyclic alkyl ring having from 3 to 6 carbon atoms; R 4 is selected from the group consisting of H and alkyl; a is 0 or an integer of from 1 to 6; b is 0 or 1; c is 0 or 1; f is 0 or an integer of 1 or 2; x is 0 or 1; y is 0 or an integer of from 1 to 3; and z is 0 or an integer of from 1 to 3.

  一种在S1P3受体上具有激动剂活性的新化合物，其由以下式I表示： 其中 X选自CR3、N和NO组成的群体； Y选自CR3、N和NO组成的群体； Z选自CR3、N和NO组成的群体； 且X、Y和Z中至少有一个是N或NO； V为O或NOR4； R1为芳基； R2为芳基； R3选自H和烷基的群体；其中2个R3群体可以共同形成具有3至6个碳原子的环烷基环； R4选自H和烷基的群体； a为0或1至6的整数； b为0或1； c为0或1； f为0或1或2的整数； x为0或1； y为1至3的整数；以及 z为1至3的整数。
• Benzofuran derivatives, their production and use
  申请人：——

  公开号：US20020160996A1

  公开（公告）日：2002-10-31

  Compounds represented by the formula: 1 wherein R 1 and R 2 are hydrogen atom, a hydrocarbon group or a heterocyclic group, or R 1 and R 2 may form, together with the adjacent carbon atom, a 3- to 8-membered homocyclic or heterocyclic ring, W indicates (i) a group represented by the formula: 2 wherein ring B indicates a 5- to 7-membered ring, or (ii) a group represented by the formula: 3 wherein R 4 indicates (1) an aliphatic hydrocarbon group, which may be substituted with an aromatic group, or (2) an acyl group containing an aromatic group, R 5 is hydrogen atom, a C 1-6 alkyl, or an acyl group, provided that, when W is Wa, R 3 is hydrogen atom, a hydrocarbon group or a heterocyclic group, when W is Wb, R 3 indicates a C 6-14 aryl group, or salts thereof or prodrugs thereof have an excellent action to inhibit neurodegeneration and the like as well as an excellent brain penetrability and are low in the toxicity, thereby being useful as prophylactic or therapeutic drugs for nerve degenerative diseases and the like.

  由以下公式代表的化合物： 其中 R1 和 R2 是氢原子、烃基或杂环基，或者 R1 和 R2 可以与相邻的碳原子一起形成 3 至 8 个成员的同环或杂环环，W 表示 (i) 由以下公式代表的基团： 其中环 B 表示一个 5 至 7 个成员的环，或者 (ii) 由以下公式代表的基团： 其中 R4 表示 (1) 可以用芳香基取代的脂肪烃基，或者 (2) 含有芳香基的酰基，R5 是氢原子、C1-6 烷基或酰基，提供当 W 是 Wa 时，R3 是氢原子、烃基或杂环基，当 W 是 Wb 时，R3 表示一个 C6-14 芳基，或其盐或前药具有优异的抑制神经退行性等作用，以及出色的脑透过性，毒性低，因此可用作预防或治疗神经退行性疾病等的药物。
• [EN] SELECTIVE ESTROGEN RECEPTOR DOWN-REGULATORS (SERDS)<br/>[FR] RÉGULATEURS NÉGATIFS SÉLECTIFS DU RÉCEPTEUR DES OESTROGÈNES (SERD)
  申请人：XAVIER UNIV OF LOUISIANA

  公开号：WO2017192991A1

  公开（公告）日：2017-11-09

  The present disclosure relates to orally bioavailable selective estrogen receptor down-regulators (SERDs) and the synthesis of the same. Further, the present disclosure teaches the utilization of the orally bioavailable selective estrogen receptor down-regulators (SERDs) in a treatment for proliferative diseases, including cancer, particularly breast cancer, and especially ER+ breast cancer.

  本公开涉及口服可生物利用的选择性雌激素受体下调剂（SERDs）及其合成。此外，本公开教导了如何利用口服可生物利用的选择性雌激素受体下调剂（SERDs）来治疗增殖性疾病，包括癌症，特别是乳腺癌，尤其是ER+乳腺癌。
• Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells
  申请人：——

  公开号：US20040034049A1

  公开（公告）日：2004-02-19

  An agent for promoting the proliferation or differentiation of a stem cell and/or neural progenitor cell, comprising a compound represented by Formula: 1 wherein each of R 1 and R 2 is H, a hydrocarbon group or a heterocyclic group, or taken together with the adjacent carbon atom to form a ring, R 3 is H, a hydrocarbon group or a heterocyclic group, W is a group represented by Formula: 2 wherein Ring A is an optionally substituted benzene ring, Ring B is an optionally substituted 5- to 7-membered nitrogen-containing heterocyclic ring, R 4 is an acyl group having an aliphatic hydrocarbon group, which is substituted by an aromatic group and may have a further substitutent, or aromatic group, R 5 is H, C 1-6 alkyl or acyl, R 4c is an aromatic group, an aliphatic hydrocarbon group or acyl, and X is O or S; Y is O, S or NH, Ring C is an optionally substituted benzene ring, or a salt or prodrug thereof is provided.

  一种用于促进干细胞和/或神经前体细胞增殖或分化的药剂，包括由公式1表示的化合物，其中R1和R2中的每一个是H、烃基或杂环基，或与相邻的碳原子结合形成环，R3是H、烃基或杂环基，W是由公式2表示的基团，其中环A是可选取代的苯环，环B是可选取代的含氮5-至7元杂环环，R4是取代芳香基的脂肪烃基的酰基，可以有进一步的取代基，或芳香基，R5是H、C1-6烷基或酰基，R4是芳香基、脂肪烃基或酰基，X是O或S；Y是O、S或NH，环C是可选取代的苯环，或其盐或前药。